baber/WOPTO huggingface dataset:
Patent NZ-217496-A (NZ)
Title: Dioxolanyl- and dioxanyl-substituted diazoles and triazoles; dioxolane and dioxane intermediates; and plant antifungal compositions
Inventor: COLLE R
IPC: A01N43/653
Filed: 1986-09-08
Abstract: Disclosed are compounds, having the general formula: wherein:m = 0, 1, 2; n = 0, 1 with the condition that when m = 0, also n = 0;p = 0, 1; q = 1, 2;X is either oxygen or sulphur;A = N, CH;R is H, CH₃, F;R₁ is selected from chlorine, bromine, fluorine, CF₃, phe­nyl, C₁-C₂-alkoxy, C₁-C₂-haloalkoxy, alkylthio, haloalkyl­thio, wherein the halogen is Cl, Br, F;R₂ is selected from H, chlorine, bromine, fluorine;R<sub>f</sub> is selected from the group formed by alkyls containing from 2 to 4 carbon atoms, and containing at least 4 atoms of halogen selected from F, Cl and Br, of which at least 3 are F atoms; alkenyls and alkynyls containing up to 4 carbon atoms, containing at least 2 F atoms and, optionally, other halogens selected between Cl and Br.
Patent NZ-232951-A (NZ)
Title: Preparation of yeast cells immobilised in calcium alginate beads and use in preparing alcoholic drinks
Inventor: HILL FRANK
IPC: C12G1/06
Filed: 1990-03-16
Abstract: 2.1 Yeast cells can be immobilised in calcium alginate feeds and can be used in this form for alcoholic fermentation. Additionally coating the beads with a cell-free calcium alginate layer ensures that no cells are washed out. 
<??>2.2 A defined washing of the calcium alginate beads has the result that, in a simple manner, prepared alcoholic beverages remain clear and that in particular during sparkling wine fermentation neither crystalline turbidity caused by the formation of calcium tartrate and calcium malate nor fine turbidity caused by washed-out yeast cells occurs. 
<??>2.3 Preparation of immobilised yeasts and their use in the production of alcoholic beverages.
Patent NZ-243782-A (NZ)
Title: Kluyveromyces host/vector couple and its use
Inventor: FLEER REINHARD
IPC: C12N9/12
Filed: 1992-07-30
Abstract: The present invention relates to new recombinant yeasts highly stable in a complex medium, characterised in that they are yeasts of the genus Kluyveromyces in which an essential gene is not functional, and which contain a vector carrying a functional copy of the said gene.
Patent NZ-271313-A (NZ)
Title: Pharmaceutical use of oxa-or thia-diazole-substd. azabicyclic ring compounds
Inventor: BYMASTER FRANKLIN PORTER
IPC: A61K31/41
Filed: 1994-08-18
Abstract: The present invention relates to a novel method for treating a mammal suffering from or susceptible to schizophrenia and schizophreniform diseases.
Patent NZ-301594-A (NZ)
Title: Generating a plurality of chemical compounds in a spatially arranged array whereby the scaffold is an aminimide, imidazolone, sulphonylaminimide, and/or phophonylaminimide
Inventor: ZAMBIAS ROBERT A
IPC: G06F17/30
Filed: 1996-01-19
Abstract: A method for constructing an array of synthetic molecular constructs, by forming a plurality of molecular constructs having a scaffold backbone of a chemical molecule comprising a linear, branched or cyclic organic compound having at least atoms of carbon, nitrogen, sulfur, phosphorus, or combinations thereof, and at least one location on the molecule capable of undergoing reaction with other molecules for attachment of at least one structural diversity element; laying out an array possessing a logical ordering of sub-arrays of the molecular constructs; providing each sub-array with molecular constructs having the scaffold backbone and at least one structural diversity element which is different from the others; and relating each sub-array within the array to all other sub arrays by the difference in the structural diversity elements.
Patent NZ-331963-A (NZ)
Title: Coating solution comprising fine particles of inorganic compounds, and use in forming a selectively transmitting film for UV protection
Inventor: ADACHI KENJI
IPC: C09D7/61
Filed: 1998-09-16
Abstract: coating solution for forming a selectively transmitting film which is effective for cutting off ultraviolet radiation in a wide range of wavelengths up to about 400 nm, maintains its stability and effect for a long time, has also a power of cutting off heat rays and a controlled transmittance of visible light, has any desired color produced by the addition of fine particles of an appropriate inorganic substance, and is applicable to glass in any existing building, or the like by a simple and inexpensive method using an appropriately selected binder, and a selectively transmitting film and a selectively transmitting multilayer film which are formed from the solution.  The solution is a dispersion of fine particles having an average diameter of 100 nm or less of at least one of ruthenium oxide, titanium nitride, tantalum nitride, titanium silicide, molybdenum silicide, lanthanum boride, iron oxide and iron (III) hydroxide oxide.  It may also contain at least one of the alkoxides of silicon, zirconium, titanium and aluminum, and partially hydrolyzed polymers of those alkoxides, or a synthetic resin as a binder. The selectively transmitting film is formed by coating a base material with the solution, and hardening it.  The selectively transmitting multilayer film has another film formed on the selectively transmitting film and containing at least one of the alkoxides of silicon, zirconium, titanium and aluminum, partially hydrolyzed polymers of those alkoxides, and a synthetic resin.
Patent NZ-332489-A (NZ)
Title: Pour-through and pitcher mounted water filter
Inventor: MOZAYENI B ROBERT
IPC: C02F1/50
Filed: 1997-05-02
Abstract: A gravity fed, pour-through water filtration device (10) includes a chamber housing (11), a spiral filter (30) including a "biocidal" material and an annular holding chamber. Several porous separator disks, a volume of filtration media (64), and a cyst membrane (70) are positioned beneath the spiral filter and holding chamber. The device (10) is effective in significantly reducing the number of bacteria, viruses and cysts present in the filtrated water. The filtration device is a fully scalable design for use in municipal flow-through and other systems. The configuration of the flow path may be a thin channel of minimal width lined with granular active material to improve the efficiency of the filtration and treatment process while keeping to a minimum the resistance to flow. The spiral or helical geometry lends itself to compact arrangement where space is limited. The fluid channel lined with granular material disrupts laminar flow and creates an environment inhospitable for the growth of bacterial contaminants such as "biofilm" typically found and described in dental water treatment lines.
Patent NZ-333533-A (NZ)
Title: Vehicle racking system with pivotable side frames
Inventor: BURKE MALCOLM ROBERT
IPC: B60R9/045
Filed: 1998-12-23
Abstract: This racking system for a pickup vehicle comprises a pair of side frames which are pivotable from a lowered position to an extended position; and a pair of end frames including tie bars for attachment to the side frames, and are further characterised in that each side frame is automatically locked in place by pivotable movement of the side frame.
Patent NZ-334906-A (NZ)
Title: A sulphonamido pentanoic acid derivative useful as an interleukin-1-beta converting enzyme inhibitor
Inventor: ALBRECHT HANS P
IPC: A61P25/28
Filed: 1997-10-09
Abstract: The sulphonamido pentanoic acid derivative or a pharmaceutically acceptable salt, amide, ester or prodrug thereof has the formula I wherein: R1 is a group of formula II; R3 is H, alkyl, -(CH2)n aryl or -(CH2)n heteroaryl; R4, R5, R6 and R7 are independently alkyl, -(CH2)n aryl or -(CH2)n heteroaryl; each n is 0 to 6; each m is 0 to 3; A is alanine, leucine, isoleucine, proline, phenylalanine, glycine, tyrosine, serine, threonine, tryptophan, cysteine, methionine, valine, asparagine, glutamine, aspartic acid, lysine, glutamic acid, arginine, or histidine; R2 is -(CH2)n-Z; Z is alkyl or optionally substituted aryl, heteroaryl, cycloalkyl or fluorenyl or a group of formula III and each RQ is independently H or alkyl. A pharmaceutical composition thereof is used for inhibiting interleukin-1b converting enzyme, inhibiting caspase-4, treating or preventing a stroke or a treating inflammatory disease.
Patent NZ-336582-A (NZ)
Title: Web delivery arrangement with tension device distanced from storage reel but in immediate vicinity of process line
Inventor: BORRENSEN HARALD E
IPC: B65H23/182
Filed: 1995-10-21
Abstract: Apparatus is disclosed for delivering a web of material (1) from a storage reel to a process line (16). A unit which functions to control web tension is distanced from the storage reel and placed in the immediate proximity of the process line.  Divided out of 296230
Patent NZ-503140-A (NZ)
Title: Sealing system comprising at least one seal on each side of a lubricating reservoir, e.g a soaked felt washer
Inventor: WARD NEIL BARRY
IPC: A61D7/00
Filed: 2000-03-01
Abstract: A sealing system 1 includes at least one seal 5 on each side of a lubricating reservoir 4.  The sealing system is located between the piston 3 and barrel 2 within a drench gun.  The lubricating reservoir may be a lubricant soaked felt washer.  At least one of the seals may be in the form of a flexible O-ring.
Patent NZ-506409-A (NZ)
Title: Method for regulating nicotine metabolism which involves selectively inhibiting CYP2A6 and CYP2B6
Inventor: SELLERS EDWARD M
IPC: A61K31/37
Filed: 2000-08-17
Abstract: A Pharmaceutical composition for use in treating a condition requiring regulation of nicotine metabolism to cotinine comprising an effective amount of a substance which selectively inhibits human cytochrome P450 2A6, an effective amount of an inhibitor of human cytochrome P450 2B6, optionally with a pharmaceutically acceptable carrier, diluent, or excipient, and wherein said composition exhibits a synergistic effect in the regulation of nicotine metabolism to cotinine.
Patent NZ-508620-A (NZ)
Title: Magnetic field based power transmission line communication method and system
Inventor: STEWART WILLIAM L
IPC: H04B3/54
Filed: 1999-05-07
Abstract: A method and system for communicating information between subscribers (20,22,24) over power lines (26) where the information is transmitted in the magnetic field component of the electromagnetic radiation carried over the power line (26) and the field is exciting by a MASER (50) in order to enable communication between the subscribers (20,22,24) at the various electrical sites. The MASER (50) provides an inverted atomic population by pumping directly, through a Q-switch (58) and a synthetic aperture lens (60), into the atomic population of the electromagnetic wave carried over the power line (26) to produce acoustic wave oscillation at the appropriate atomic transition frequency. The MASER (50) output is transmitted within the existing magnetic flux envelope created by the magnetic field and the power line (26) acts as a magnetic waveguide for the coherent magnetic frame emissions from the MASER (50).  Inductive coupling is used to receive the transmitted information.
Patent NZ-509614-A (NZ)
Title: Edge-lit illumination system
Inventor: FORSTER JOHN HENRY
IPC: F21Y103/00
Filed: 1999-09-01
Abstract: An edge-lit illumination system comprising a light transmitting sheet (10) and a light source (13, 14); the light source (13, 14) being positioned in proximity to and adjacent to an edge of said light transmitting sheet (10), characterised in that at least one of the two opposing surfaces (11, 12) of said light transmitting sheet (10) carries markings such that said markings are disposed randomly within each of at least one nominal area of said at least one surface.
Patent NZ-512455-A (NZ)
Title: Computerised disease management and therapy optimisation using critical curve parameters
Inventor: ILIFF EDWIN C
IPC: G06F19/00
Filed: 1998-03-13
Abstract: To assist the evaluation of disease progression for a computerized health advice and planning system a critical curve for a particular disease is provided and by comparing the health parameters taken from an electronic medical record corresponding to a particular patient having the particular disease to the critical curve, suitable health assessment information is derived.  The diagram illustrates the process in greater detail.
Patent NZ-515118-A (NZ)
Title: 4-[4-[4-[4-[[-1,3- dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one derivatives useful as antifungal agents
Inventor: MEERPOEL LIEVEN
IPC: A61P31/10
Filed: 2000-04-20
Abstract: An azole containing ether derivative or a N-oxide form, a salt, a quaternary amine or stereochemically isomeric form thereof has the formula (I) and are useful fro treating fungal infections wherein: D is a radical of formula of formula (II) the dotted line is the bond attaching D to the remainder of the compound of formula (I); X is N or CH; R3 is hydrogen or halo and R4 is halo; -A-B- is a bivalent radical of formula: i) -N=CH-, (ii) -CH=N-, (iii) -CH=CH- or (iv) -CH2-CH2, wherein one hydrogen atom in the radicals (i) and (ii) may be replaced by alkyl and one or more hydrogen atoms in radicals (iii) and (iv) may be replaced by alkyl; Alk is alkanediyl; Y is optionally substituted alkanediyl and R1 is hydrogen, alkyl or arylalkyl and R2 is hydrogen, alkyl or arylalkyl; or together R1 and R2 may form an optionally substituted morpholinyl, pyrrolidinyl, piperidinyl, homopiperidinyl, piperazinyl or phthalimid-1-yl.
Patent NZ-517518-A (NZ)
Title: An improved fire resistant air transfer grille or damper
Inventor: MANN ROBERT MCGOWAN
IPC: A62C2/06
Filed: 2000-09-25
Abstract: A  fire  resistant air transfer grille or damper  (10) includes an outer frame (12) and a plurality of slats  (14). Each  of the slats (14) is provided with an intumescent core and  is  positioned  in  one of a  number  of  predetermined positions  within  the outer frame (12).  The  predetermined positions  are  determined  by a  number  of  recesses  (26) provided  in the outer frame (12). The outer frame (12)  may be  formed as two separate frame components (16, 18), and is preferably  made from steel. The slats (14)  are  preferably formed  from aluminium with an intumescent material provided within  the  aluminium slat (14) to provide the  intumescent core.  Each  of the slats (14) also preferably  includes  an elongate  channel member (30, 32) along each of two  of  its side  edges, wherein the elongate channel members  (30,  32) of  each  of the slats (14) engage within the recesses  (26) in the outer frame (12).
Patent NZ-518478-A (NZ)
Title: Method of treating pyschotic episodes, mood disorders, anxiety using phosphodiesterase-10 inhibitors, specifically papaverine
Inventor: LEBEL LORRAINE ANN
IPC: G01N33/68
Filed: 2002-04-19
Abstract: A selective PDE10 inhibitor is used in the manufacture of a medicament for treating a disorder comprising a deficiency in cognition selected from reading disorder, mathematics disorder or a disorder of written expression, or for treating an anxiety or psychotic disorder selected from schizophrenia of the paranoid, disorganized, catatonic, undifferentiated or delusional type, psychosis induced by alcohol, amphetamine, cannabis, cocaine, hallucinogens, inhalants, opioids or phencyclidine or drug addiction. Preferably the selective PDE10 inhibitor is papaverine.
Patent NZ-521491-A (NZ)
Title: Fiber cement building materials with low density additives and cellulose fibers
Inventor: GLEESON JAMES
IPC: C04B18/08
Filed: 2001-03-09
Abstract: A building material formulation used to form a building product, comprising: a hydraulic binder; an aggregate; fibers comprising 4%-15% cellulose fibers of the formulation by weight; and a low density additive, wherein the low density additive lowers the density of the building material to 1.2g/cm3 or less and is selected to maintain the moisture expansion of the material at a level of 0.17% or less is disclosed. This building material formulation includes low density additives such as volcanic ash, hollow ceramic microspheres or a combination of microspheres and volcanic ash or other low density additives into cementitious cellulose fiber reinforced building materials. This formulation is lightweight or low density as compared to current fiber cement products without the increased moisture expansion and freeze-thaw degradation usually associated with the addition of lightweight inorganic materials to fiber cement mixes. The low density additives also give the material improved thermal dimensional stability.
Patent NZ-525311-A (NZ)
Title: Method for assembly of an aquaculture apparatus
Inventor: NICCOLI GEORGE
IPC: A01K61/00
Filed: 2003-04-15
Abstract: A method for assembling an aquaculture apparatus (10) having a support pontoon (12, 16, 17) and a net (14) suspended underneath in use for containing aquatic life, the method comprising the steps of: installing a support means on the pontoon for supporting the net prior to the net being positioned in an operational position; positioning the net on the support means and coupling the net to the pontoon; and removing the support means from the pontoon so that the net moves into the operational position.
Patent NZ-528042-A (NZ)
Title: Nicotinic receptor agonists particularly DMPP for the treatment of inflammatory diseases of the lungs
Inventor: CORMIER YVON
IPC: A61P11/00
Filed: 2002-03-25
Abstract: Disclosed is the use of nicotine receptor agonists, particularly dimethylphenylpiperazinium or DMPP , for treating inflammatory diseases, including a variety of pulmonary diseases. Such agonists have fewer side effects than other anti-inflammatory drugs, such as steroids. Moreover, these agonists can be used alone or in combination with other anti-inflammatory drugs to alleviate pulmonary diseases. Specific diseases include asthma , chronic obstructive pulmonary disease ( COPD ), interstitial pulmonary fibrosis ( IPF ), sarcoidosis , Hypersensitivity pneumonitis ( HP ), and Bronchitis obliterans with organizing pneumonitis ( BOOP ).
Patent NZ-529633-A (NZ)
Title: Adjustable implantable genitourinary device
Inventor: BURTON JOHN H
IPC: A61F2/00
Filed: 2003-11-19
Abstract: An exercise apparatus comprising a resiliently flexible substantially cylindrical body with at least two spaced apart handles for gripping by a user. (62) Divided out of 518399
Patent NZ-532247-A (NZ)
Title: Conduit, typically downpipe, with securement to structure concealed by downpipe after installation
Inventor: GRIFFIN CHARLES JAMES REYNOLDS
Filed: 2004-04-07
Abstract: A conduit, typically a downpipe 10, is fastened to a structure (typically a building wall, not shown) via a securement 100 which is concealed by the downpipe after installation. The downpipe and securement have interengaging respective tracks and inwardly directed collinear engaging portions which are stated to be advantageous in installations on weatherboard having an angled surface relative to the longitudinal axis of the conduit.
Patent NZ-536691-A (NZ)
Title: Drug delivery container stored in sachet with zeolite gas adsorber
Inventor: CUNEY SANDRINE MIREILLE PAULET
IPC: A61K47/10
Filed: 2003-05-16
Abstract: A drug delivery assembly includes a pressurized container 10 holding a drug formulation with a propellant, a sealed enclosure 12 which surrounds the container and is made of a moisture impermeable material, and a gas adsorbing material 24 within the enclosure. The gas adsorbing material is a microporous zeolite or molecular sieve having a pore opening size between 4 Angstrom and 20 Angstrom.
Patent NZ-537612-A (NZ)
Title: Apparatus for applying ink indicia to boards
Inventor: SHULMAN THOMAS L
IPC: B41J3/28
Filed: 2003-06-24
Abstract: In an apparatus for applying ink patterns on oriented strand boards, the boards are serially moved closely adjacent to and past ink jets, and ink is deposited on the boards. To deposit the ink accurately on the boards they are advanced by pinch and drive rollers, which also ensure that the boards are flat as they move past the jets. Detectors are used to detect boards, which cannot be flattened or are irregular in shape and in such a case the ink jets are moved to avoid impact by an irregular board. During printing, the panels and the ink jets are about 0.0625 inches to about 0.125 inches apart, and the panels are moved at a rate of about 150 ft/minute to 600 ft/minute.
Patent NZ-537733-A (NZ)
Title: Total lime and sulfide free dehairing process of skin or hides using animal and/or plant enzymes
Inventor: ROSE CHELLAN
IPC: C14C1/06
Filed: 2003-03-24
Abstract: A method for unhairing animal skins or hides using a total lime and sulfide free enzymatic solution comprises preparing an enzymatic solution from animal or plant tissue, optionally pre soaking the skin or hide in water, removing the soaking liquor and applying the enzymatic solution by pasting or spraying on the flesh side of the skin or hide and leaving for 10 to 24 hours at a temperature between 10oC to 60oC wherein the skins or hides are arranged flesh side to flesh side or grain side to grain side, floating the skin or hides in liquid comprising the enzymatic solution, removing the skins or hides from the liquid to produce an effluent and then unhairing the skins or hides either by scraping the hair with curved knife on a wooden beam or by using unhairing machine. Preferably the effluent produce exhibits a reduced biological oxygen demand, reduced chemical oxygen demand and/or reduced total dissolved solids.
Patent NZ-544027-A (NZ)
Title: Delivery of a drug via subconjunctival or periocular delivery of a prodrug in a polymeric microparticle
Inventor: HUGHES PATRICK M
IPC: A61K31/203
Filed: 2004-07-07
Abstract: Disclosed is the use of an ester prodrug of a retinoid in the manufacture of a medicament for the treatment or prevention of retinitis pigmentosa, proliferative vitreal retinopathy, age related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal detachment, retinal tear, uveitus, or cytomegalovirus retinitis, wherein the medicament is formulated for sustained-delivery of an active drug to a posterior part of an eye of a mammal by subconjunctival or periocular administration, wherein the prodrug is contained in a polymeric microparticle system designed to enhance the sustained-delivery of said ester prodrug of a retinoid, wherein said polymeric microparticle system is a poly(1actide-co-glycolide) microsphere suspension.
Patent NZ-544028-A (NZ)
Title: Cyclic hydroxylamine as psychoactive compounds
Inventor: PARSONS PHILIP
IPC: C07D265/30
Filed: 2004-06-01
Abstract: Disclosed are a compound of formula (I) in which X represents O or CH2, R3 and R4 each independently represents hydrogen or C1-6alkyl, p represents 0 or 1, and R represents a five- or six-membered saturated or unsaturated ring wherein R1 and R2 together represent an oxo group, or R1 and R2 each represents hydrogen, methoxy or ethoxy, or R1 and R2 together with the interjacent carbon atom represent a 1,3-dioxolane or 1,3-dioxane ring, attached via the 2-position and optionally bearing one or more methyl or ethyl groups, or a tautomer or a salt thereof; a compound of formula (II) in which R3 and R4 each independently represents hydrogen or C1-6alkyl, p represents 0 or 1, and R represents a five- or six-membered saturated or unsaturated ring wherein R1 and R2 together represent an oxo group, or R1 and R2 each represents hydrogen, methoxy or ethoxy, or R1 and R2 together with the interjacent carbon atom represent a 1,3-dioxolane or 1,3-dioxane ring, attached via the 2-position and optionally bearing one or more methyl or ethyl groups, or a tautomer or a salt thereof. The compound of formula (I) or (II) is suitable for treatment of anxiety or depression. Also disclosed is a compound of formula (III) in which R1 and R2 each represents hydrogen or together represent an oxo group, or a salf thereof. A process for the manufacture of compound of formula (II) and a pharmaceutical composition comprising a compound of formula (I) or (II), or a salt thereof are also disclosed.